Our results also show that a short overall survival time for colon cancer patients correlated with a high percentage of GPC1+ plasma exosomes one day before and one week after surgery, which suggests that the circulating GPC1+ exosomes are a marker for poor prognosis in colon cancer patients. This evidence concerns the gene GPC1 and malignant colon neoplasm.